Inve India ▾

Shanti Spintex share price & results

SHANTI SPINTEX LIMITED

Results to
Mar 2026
Ownership as of
Sept 2026
Start an Inve Case

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue322 ₹ crore—Quarterly, as filedQuarter to Mar 2026Revenue from operations as filed. No quarter a year earlier is in the series, so no change is shown.
Operating margin1.9 %—Operating profit / revenueQuarter to Mar 2026For the quarter; a change is in percentage points. No quarter a year earlier is in the series, so no change is shown.
Net profit3.0 ₹ crore—Quarterly, as filedQuarter to Mar 2026Profit after tax as filed. No quarter a year earlier is in the series, so no change is shown.
Return on equityUnavailable—Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.
Free cash flow margin0.05 %—Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)Unavailable—Trailing twelve monthsTTM · period unavailableNot in the analysed materials. No older figure is substituted.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Mar 2026

Price

₹34.9 +5.76% · +₹1.9

Last close 16 Oct 2026 · NSE · INR

Performance −45.1% 1Y

₹30.0₹40.0₹50.0₹60.0₹70.0Oct 25Nov 25Jan 26Feb 26Apr 26May 26Jul 26Aug 26Oct 26

1Y: ₹63.54 on 10 Oct 2025 → ₹34.9. High ₹71.1 (30 Oct 2025), low ₹28.01 (13 Oct 2026).

Previous close
₹33
Market cap
₹85 Cr
52-week range
₹28.01 – ₹71.1
One year
−43.25%
Price to earnings (FY ending Mar 2026)
11.57×
Return on equity (FY ending Mar 2026)
6.95%

Overview

Symbol
NSE:SHANTIDENM
Exchange
NSE
Currency
INR

Your own record

Start an Inve Case for SHANTI SPINTEX LIMITED

Free account: one company. Everything above stays public.

Write why you follow SHANTI SPINTEX LIMITED and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.